CDK-TCIP2
DK-TCIP2 is a bifunctional small molecule research compound combining a CDK9 inhibitor with a BCL6 inhibitor. It demonstrates potent anticancer activity in both in vitro and in vivo models, making it a valuable tool for investigating therapeutic strategies in lymphoma research.
Product Specifications
Field of Research
Cell Biology, Immunology & Inflammation
Molecular Formula
C52H67ClN12O8S2
Molecular Weight
1087.75
Storage Conditions
-20°C
Notes
For research use only.
Available Sizes
More Discoveries
Explore Other Products
Browse additional items from our catalog
K7571307 1.0 µg DNA
Arhgef25 sgRNA CRISPR/Cas9 All-in-One Lentivector (Rat) (Target 2)
Sign In for Pricing
View Details 
GTR15129841 1 Vial
Lentiviral mouse Qsox2 shRNA (UAS) - Lentiviral mouse Qsox2 shRNA (UAS, RFP) plasmid
Sign In for Pricing
View Details 
sc-284757A 100 mg
6-Chloro-9- (2'-deoxy-3',5'-di-O-toluoyl-b-ribofuranosyl) purine
Sign In for Pricing
View Details